Current use of MRI in patients with liver metastatic colorectal cancer: a population-based study

Affiliation auteurs!!!! Error affiliation !!!!
TitreCurrent use of MRI in patients with liver metastatic colorectal cancer: a population-based study
Type de publicationJournal Article
Year of Publication2017
AuteursPech L, Cercueil J-P, Jooste V, Krause D, Facy O, Bouvier A-M
JournalEUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
Volume29
Pagination1126-1130
Date PublishedOCT
Type of ArticleArticle
ISSN0954-691X
Mots-cléscancer registry, Colorectal cancer, Liver metastasis, mri, preoperative workup
Résumé

Background Liver MRI is recommended as the preoperative imaging strategy in liver metastatic colorectal cancers. Objective The aim of the study was to assess for the first time the use of liver MRI in a French population-based cancer registry. Patients and methods All liver-only metastatic colorectal cancers resected for their primary tumour diagnosed between 2009 and 2013 were included. Nonconditional logistic regression was used to search for associations between the MRI order and the characteristics of patients and tumours. Results The primary tumour and liver metastases were resected for cure in 30% (69/233) of cases, and in 72% of these liver MRI was performed before resection of the liver metastases. Preoperative MRI ordering was not significantly higher in patients younger than 70 years when compared with that in older patients. Among patients who did not undergo resection of their liver metastasis, 22% had undergone a liver MRI. After adjustment for comorbidities, the probability of having undergone an MRI was higher for patients managed in the university hospital (P=0.004) and lower in those managed in nonuniversity hospitals (P=0.002) compared with the mean of odds for all facilities. Patients more than or equal to 70 years were 2.4 times less likely than younger patients to undergo an MRI (P=0.043). Conclusion Liver MRI was underused in patients with colorectal liver-only synchronous metastasis undergoing curative resection for metastases and in elderly patients. Copyright (C) 2017 Wolters Kluwer Health, Inc. All rights reserved.

DOI10.1097/MEG.0000000000000933